Revolution Medicines, Inc. (RVMD) Total liabilities 2019–2025
Revolution Medicines, Inc. (RVMD) total liabilities at each fiscal year-end, per SEC filings.
$723.2MFY2025 · since FY2019: $68.0M → $723.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $723.2M | +146.7% |
| FY2024 | $293.1M | +24.5% |
| FY2023 | $235.5M | +85.8% |
| FY2022 | $126.7M | -6.4% |
| FY2021 | $135.4M | +46.0% |
| FY2020 | $92.7M | +36.4% |
| FY2019 | $68.0M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More RVMD financial trends
RVMD RevenueRVMD Net incomeRVMD Net marginRVMD Gross profitRVMD Gross marginRVMD Operating incomeRVMD Operating marginRVMD Operating cash flowRVMD Free cash flowRVMD Capital expendituresRVMD Return on equityRVMD Stock buybacksRVMD Dividends paidRVMD Total assetsRVMD Shareholders’ equityRVMD overview →